1. Zhang S, Cui B, Lai H, Liu G, Ghia EM, Widhopf GF 2nd, Zhang Z, Wu CC, Chen L, Wu R, Schwab R, Carson DA, Kipps TJ. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17266-71. doi: 10.1073/pnas.1419599111. Epub 2014 Nov 19. PMID: 25411317; PMCID: PMC4260559.
2. Liu D, Gunther K, Enriquez LA, Daniels B, O'Mara TA, Tang K, Spurdle AB, Ford CE. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target. Sci Rep. 2020 Aug 17;10(1):13906. doi: 10.1038/s41598-020-70924-z. Erratum in: Sci Rep. 2022 Jun 28;12(1):10918. doi: 10.1038/s41598-022-15043-7. PMID: 32807831; PMCID: PMC7431863.